PCRX vs AMPH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 03, 2026
PCRX
AMPH
Investment Advisor Scores
AMPH
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | AMPH | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.25 | 0 | Tie |
| PEG Ratio | 11.2121 | 2.77 | AMPH |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.2% | 5.4% | PCRX |
| Earnings Growth | -30.0% | 4.7% | AMPH |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 58.6/100 | 37.0/100 | PCRX |
| Profit Margin | 2.0% | 10.8% | AMPH |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | PCRX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
NeutralMixed signals - no dominant trend phase, RSI 51
AMPH
MarkupPrice above SMA50, rising 50-day trend (9.6% over 20 days), RSI 59
Fundamentals Snapshot
| Metric | PCRX | AMPH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.3 | 9.6 |
| Trailing P/E | 71.5 | 15.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.8% | 0.5% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 0.35 | 1.69 |
| Dividend Yield | — | — |